Close

Form 3 LEXICON PHARMACEUTICALS, For: Sep 25 Filed by: Alexander Kristen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. GOOGL
3. MSFT
4. SPY
5. CMG
6. LRCX
7. INTC
8. SNAP
9. IBM
10. BA


September 27, 2021 4:07 PM EDT
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Alexander Kristen
(Last) (First) (Middle)
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR
(Street)
THE WOODLANDS TX 77381
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/25/2021 		3. Issuer Name and Ticker or Trading Symbol
LEXICON PHARMACEUTICALS, INC. [ LXRX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Finance and Accounting
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 9,000
D
 
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 06/12/2027 Common Stock 9,184 16.4 D  
Stock Option (Right to Buy)   (2) 02/08/2028 Common Stock 4,000 9.79 D  
Stock Option (Right to Buy)   (3) 02/07/2029 Common Stock 4,800 5.16 D  
Restricted Stock Units   (4)   (4) Common Stock 3,200 (5) D  
Stock Option (Right to Buy)   (6) 02/06/2030 Common Stock 5,800 3.31 D  
Restricted Stock Units   (7)   (7) Common Stock 10,800 (5) D  
Stock Option (Right to Buy)   (6) 02/11/2031 Common Stock 4,000 8.38 D  
Restricted Stock Units   (7)   (7) Common Stock 8,100 (5) D  
Explanation of Responses:
1. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (6/12/2018) and vests 1/48th per month for each month of service thereafter.
2. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter.
3. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter
4. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.
5. Each restricted stock unit represents a contingent right to receive one share of common stock.
6. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
7. Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
/s/ Kristen L. Alexander 09/27/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings